Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer

Author： Allen Wendy L Johnston Patrick G

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.6, 2005-09, pp. : 603-614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Molecular Markers for Individualized Therapy in Colorectal Cancer: Progress Towards a Pharmacogenomics Array

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 1, 2009-03 ,pp. : 70-80

Bentham Science Publishers

Access to resources Recommend Favorite

From the archives: how much progress have we really made?

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 2-3

Adis International

Access to resources Recommend Favorite

Research Highlights: Revisiting the frontiers of pharmacogenomics of colon cancer

By Falandry Claire Bonnefoy Marc Freyer Gilles

Pharmacogenomics, Vol. 12, Iss. 9, 2011-09 ,pp. : 1243-1248

Future Medicine

Access to resources Recommend Favorite

Breast cancer pharmacogenomics: where we are going

By Newman William G Flockhart Dave

Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. : 629-631

Future Medicine

Access to resources Recommend Favorite

Progress in Colorectal Cancer Chemotherapy: How Far Have We Come, How Far to Go?

By Royce M.E.

Drugs & Aging, Vol. 17, Iss. 3, 2000-09 ,pp. : 201-216

Adis International

Access to resources Recommend Favorite